Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-26 Sale |
2023-09-26 4:30 pm |
REATA PHARMACEUTICALS INC | RETA | Patni Rajiv EVP, Chief R&D Officer |
45,000 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-15 Option Award |
2025-01-16 08:04 am |
N/A 2035-01-15 |
BioXcel Therapeutics Inc. | BTAI | Patni Rajiv Director |
44,000 | $0 | 44,000 (Direct) |
View |
Ownership |
2025-01-16 08:03 am |
N/A 2033-12-08 |
BioXcel Therapeutics Inc. | BTAI | Patni Rajiv Director |
0 | $0 | 15,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 8:55 pm |
2025-06-05 2034-06-05 |
Quince Therapeutics Inc. | QNCX | Patni Rajiv Director |
13,500 | $0 | 13,500 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-15 6:14 pm |
N/A 2034-02-15 |
Quince Therapeutics Inc. | QNCX | Patni Rajiv Director |
54,000 | $0 | 54,000 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-14 4:26 pm |
N/A 2033-06-12 |
REATA PHARMACEUTICALS INC | RETA | Patni Rajiv EVP, Chief R&D Officer |
135,000 | $0 | 135,000 (Direct) |
View |